No specific prognostic model has been developed for patients readmitted to the intensive care unit (ICU) during the same hospitalisation. This study assesses the performance of the Acute Physiology and Chronic Health Evaluation (APACHE) II predicted mortality measured at the time of ICU readmission and whether incorporating information prior to the readmission will improve its performance to predict hospital mortality of patients readmitted to ICU during the same hospitalisation. A total of 602 readmissions during the same hospitalisation between 1987 and 2002 were identified. The first admission APACHE II predicted mortality was significantly associated with the hospital mortality only in the subgroup of patients readmitted within seven days of ICU discharge (odds ratio 1.16, 95% confidence interval 1.01 to 1.34; P=0.035). In the subgroups of patients readmitted within seven days of discharge, the readmission APACHE II predicted mortality was also significantly better than the first admission APACHE II predicted mortality in discriminating between survivors and non-survivors (area under the receiver operating characteristic curve: 0.785 vs. 0.676, z statistic=2.93; P=0.003). Incorporating the first admission APACHE II predicted mortality to the readmission APACHE II predicted mortality, either by multilevel likelihood ratios or logistic regression, did not significantly improve its discrimination (area under the receiver operating characteristic curve: 0.792 vs. 0.785, z statistic=0.52; P=0.603). Our results suggested that information on prior ICU admission during the same hospitalisation is not as important as the severity of illness measured at the time of readmission in determining the mortality of intensive care readmissions during the same hospitalisation.
Intensive care unit (ICU) readmission during the same hospitalisation is associated with significant morbidity and mortality [1] [2] [3] [4] . The average proportion of ICU readmission ranges between five and 10% and has remained relatively unchanged in both North America and Europe over the past 10 years [3] [4] [5] [6] [7] . The Australian Council of Healthcare Standards has adopted unplanned readmission as one of the clinical indicators of intensive care patient management but data on ICU readmission from Australasian ICUs are sparse [7] [8] [9] [10] [11] .
Accurate risk adjustment for outcomes of critically ill patients is important for clinical audit and research purposes. So far, no specific risk adjustment model has been developed for patients readmitted to the ICU during the same hospitalisation. In the previous studies that evaluated ICU readmissions 4 , the Acute Physiology and Chronic Health Evaluation (APACHE) II model was used for risk adjustment. However, ICU readmissions were not included in the original cohort of the APACHE II model 12 . Risk adjustment for ICU readmission is difficult because the risk of death of a patient is complicated by the course of the disease and therapy during the prior ICU admission. The information of the patient prior to ICU readmission can potentially induce a bias, similar to 'lead-time bias' as described by Angus 13 , that can affect the performance of a prognostic test.
The Bayesian approach to prediction has been widely used in many decision making processes in medicine and law 14, 15 . Based on the Bayes' theorem, prior probability (i.e. pre-test probability) of an event will affect the post-test probability of the event of a prediction test 16 . In patients who are readmitted to the ICU during the same hospitalisation, the probability of death prior to the ICU readmission is likely to be related to events prior to the ICU readmission such as the severity of the illness leading to their first ICU admission (e.g. the first ICU admission APACHE II predicted mortality), admission source of the first ICU admission, type of first ICU admission (elective vs. non-elective), length of stay of the first ICU admission and the time interval between ICU discharge and readmission. Therefore, the probability of death as predicted by a prognostic test, applied at the time of ICU readmission, may theoretically be improved if we incorporate these factors.
So far, no specific prognostic model has been developed for patients readmitted to the ICU during the same hospitalisation. Using a Bayesian approach to improve the prediction of mortality of ICU readmissions also has not been described. This study assesses the performance of the APACHE II predicted mortality when measured at the time of ICU readmission (the readmission APACHE II predicted mortality) and whether incorporating information on risk of death prior to the ICU readmission improves the discrimination of the readmission APACHE II predicted mortality.
METHoDS

Study population
This cohort study utilised the clinical database of the tertiary ICU at the Royal Perth Hospital in Western Australia. The clinical database contains details of all ICU admissions between 1987 and 2002, including demographic factors, admission diagnosis, admission source, APACHE II scores and comorbidities, and ICU and hospital survival. The data are reviewed annually for internal consistency and no patients were lost to follow-up or had missing data. Details of the 'population', from which ICU readmissions during same hospitalisation were identified, including demographic factors, case-mix and the length of ICU and hospital stay are described in our previous publications [17] [18] [19] . Patients who had a diagnosis in their first ICU admission or readmission that were excluded from the original APACHE II cohort (e.g. coronary artery graft surgery, burns, snake bite) 12 and readmissions after the first ICU readmission during the same hospitalisation were also excluded in this study. The patients' name and address details were removed before analysis and a formal ethics approval was waived by the Royal Perth Hospital Ethics Committee.
Statistical analyses
Using the traditional Bayesian approach analysis 20 , the first ICU admission APACHE II predicted mortality was used as the pre-test probability (P1).
Likelihood ratio (LR) of a diagnostic/prognostic test represents the likelihood that a positive test result would be found in a patient with an event or disease as opposed to without. LR is usually calculated using a single test result cut-off point. LR above one signifies an increase in likelihood of an event and values below one signify a decrease in likelihood. In this study we calculated multilevel of likelihood ratios for the readmission predicted mortality by categorising the readmission APACHE II predicted mortality into 10 risk strata (0 to 0.1, 0.1 to 0.2, 0.2 to 0.3, 0.3 to 0.4, 0.4 to 0.5, 0.5 to 0.6, 0.6 to 0.7, 0.7 to 0.8, 0.8 to 0.9, 0.9 to 1.0). The post-test probability of death (P2) was calculated as P1×LR / .
Logistic regression was used as an alternative approach to assess whether other events prior to ICU readmission were related to hospital mortality while adjusting for the severity of the illness measured at the time of readmission by the readmission APACHE II predicted mortality. The events prior to ICU readmission evaluated included the severity of acute illness leading to the first ICU admission (the first admission APACHE II predicted mortality), source of the first ICU admission, type of the first admission (elective vs. non-elective), length of stay of the first ICU admission and the time interval between ICU discharge and readmission. These pre-readmission variables were selected because these factors are theoretically most likely related to the risk of death before the ICU readmission.
Multicollinearity can create an association between a predictive variable and an outcome variable if this predictive variable is closely correlated (e.g. linear correlation >0.8) to another significant predictive variable in a multivariate analysis 21 . To avoid multicollinearity, we used Pearson correlation to assess the correlations between the first admission and readmission APACHE II prediction mortality before they were analysed simultaneously in a multivariate model. Interaction terms were confined to between the first admission and readmission APACHE II predicted mortality, and between the time interval between ICU discharge and readmission and the first admission predicted mortality. Each predictive variable in the interaction terms was first centred (i.e. each individual value minus the mean) to reduce the risk of multicollinearity between an individual predictive variable and its derived interaction terms. In the final logistic regression analysis, only the first admission APACHE II predicted mortality, readmission APACHE II predicted mortality and variables with a P value <0.25 were retained. In the final logistic model that contains both the first ICU admission and readmission APACHE II predicted mortality, a unit increase in the readmission APACHE II predicted mortality is associated with a unit increase in log odds of death similar to a continuous LR.
We stratified the ICU readmissions into early (≤seven days) or late (>seven days) readmissions as a priori designation to assess whether the time interval between ICU discharge and readmission is an effect modifier on the relationship between events prior to ICU readmission and mortality. We used the area under the receiver operating characteristic (RoC) curve to assess the discrimination performance of the model. The difference in areas under the RoC curves derived from the same cases was analysed by the z statistic as described by Hanley and McNeil 22 . A P value less than 0.05 was regarded as significant, all tests were two-tailed and no adjustment was made for multiple tests. All statistical analyses were performed by SPSS statistical software (version 13.0 for Windows, SPSS Inc., U.S.A.).
RESULTS
A total of 602 ICU readmissions during the same hospitalisation between 1987 and 2002 were identified, of which 424 (70.4%) were readmitted within seven days of ICU discharge. The mean time interval between ICU discharge and readmission was 8.2 days (standard deviation 12.6, median 4.0, range 147). The first admission APACHE II predicted mortality (standardised mortality ratio) and readmission APACHE II predicted mortality (standardised mortality ratio) was 18.3% (1.28, 95% confidence interval [CI]: 1.08 to 1.51) and 25.1% (0.93, 95% CI: 0.79 to 1.10) respectively. The patient characteristics are described in Table 1 . The patients who were readmitted after seven days of ICU discharge had a significantly higher severity of acute illness (the first admission APACHE II score and predicted mortality) and longer length of ICU stay in their first ICU admission when compared to patients readmitted within seven days of ICU discharge ( Table 2) .
Based on the multilevel likelihood ratios, the readmission APACHE II predicted mortality appeared to be most useful when the predicted mortality was very high (>80%) or very low (<10%) ( Table 3 ) ( Figure 1) .
The Pearson correlation between the first admission and readmission APACHE II predicted mortality of the early (≤seven days) and late (>seven days) readmissions was 0.231 and 0.357, respectively. The readmission APACHE II predicted mortality was significantly associated with hospital mortality in both early and late readmissions ( Table  4 ). However, the first ICU admission APACHE II predicted mortality was only significantly associated with hospital mortality in patients who were readmitted within seven days of ICU discharge (odds , the time interval between ICU discharge and readmission, the interaction terms between the first admission and readmission APACHE II predicted mortality and between the time interval between discharge and readmission and first ICU admission APACHE II predicted mortality were not significant (P >0.25) and not retained in the final logistic regression model ( Table 4 ).
The discrimination of the first admission APACHE II predicted mortality regardless of the timing of the subsequent readmission was not strong, with the area under the RoC curve being less than 0.700 ( Table 5 ).
The discrimination of the readmission APACHE II predicted mortality was better than the first admission APACHE II predicted mortality only in patients who were readmitted within seven days of ICU discharge (area under the RoC curve: 0.785 vs. 0.676, z statistic=2.93; P=0.003). Incorporating the first admission APACHE II predicted mortality to the readmission predicted mortality, by either multilevel likelihood ratios or logistic regression, did not significantly improve its discrimination in both early (area under the ROC curve: 0.792 vs. 0.785, z statistic=0.52; The length of the first ICU admission, days between discharge and readmission, original source of ICU admission, type of original admission (elective vs. non-elective), the interaction terms between the first admission and readmission APACHE II predicted mortality and time interval between discharge and readmission and the first admission APACHE II predicted mortality were not significant and not retained in the final model. The Hosmer-Lemeshow Chi square (P=0.74) and Nagelkerke R 2 of the final model for patients readmitted within seven days was 5.2 and 0.271, respectively. The Hosmer-Lemeshow Chi square (P=0.59) and Nagelkerke R 2 of the final model for patients readmitted after seven days was 6.5 and 0.161, respectively. The odds ratio for the predicted mortality indicates an increment of 10% APACHE II predicted mortality. CI=confidence interval.
P=0.603) and late readmissions (0.699 vs. 0.694, z statistic=0.41; P=0.682) ( Table 5 ).
DISCUSSIoN
As far as we know, this is the first study specifically evaluating the use of the APACHE II predicted mortality to predict mortality of ICU readmissions during the same hospitalisation. The discrimination of the first admission APACHE II predicted mortality in patients with subsequent ICU readmission during the same hospitalisation is not strong. The first admission APACHE II predicted mortality is independently associated with hospital mortality only in early readmissions (≤seven days). However, incorporating the first admission APACHE II predicted mortality to the readmission APACHE II predicted mortality does not significantly improve its ability to discriminate between survivors and non-survivors.
The discrimination of the APACHE II predicted mortality measured at the time of first ICU admission in patients with subsequent readmission during the same hospitalisation (area under RoC <0.7000) is worse than in patients who had no readmission (>0.800) 12, 18 . There are two possible explanations why the first admission APACHE II predicted mortality has a poor discrimination in patients with readmission. on one hand, patients who are readmitted subsequently may be intrinsically similar to patients without readmission in their first ICU admission. ICU readmission occurs because of an adverse event after the first 24 hours of their first ICU admission. Evidence suggests that residual organ dysfunction and an elevated C-reactive protein concentration at the time of ICU discharge leads to a higher risk of ICU readmission 4,5,10 . We have also recently shown that the excess mortality risk associated with occurrence of organ failure after the first 24 hours of ICU admission is not fully captured by the APACHE score 23 . Therefore, the excess mortality risk associated with an adverse event leading to ICU readmission may not be fully captured by the first admission APACHE II predicted mortality. on the other hand, ICU readmission may represent an intermediate event of an intrinsically sicker group of patients, but the APACHE II predicted mortality is not capable of capturing this excess risk 13 . Evidence suggests that comorbidity is a risk factor for ICU readmission and the risk associated with comorbidities may not be fully adjusted by the APACHE II score 11, 24 . It is possible that patients with subsequent readmission have more comorbidities than patients without readmission and this excess risk is not fully captured by the APACHE II predicted mortality and hence its poor discrimination.
The severity of illness in the first ICU admission (first admission APACHE II predicted mortality) is associated with mortality only when the readmission is close to the first ICU admission. Late readmission (>seven days) is more likely to be due to a new nosocomial complication than the original acute illness leading to the first ICU admission. As such, the hospital outcome of these late readmissions is much less likely to be related to the first admission APACHE II predicted mortality. Furthermore, even in patients who are readmitted within a short time after ICU discharge (≤seven days), the severity of the illness leading to the readmission still has a more overwhelming effect on the hospital outcome than the severity of illness in their first ICU admission (OR of death: 1.50 vs. 1.16) ( Table 4 ). Incorporating the first admission APACHE II predicted mortality to the readmission APACHE II predicted mortality also does not improve its discrimination further. This may be in part explained by the fact that both the first ICU admission and readmission APACHE II predicted mortality are partly determined by two same risk factors, the age and chronic health evaluation, to generate the predicted mortality. Although the readmission APACHE II predicted mortality was better than first admission APACHE II predicted mortality in predicting hospital mortality of ICU readmissions, its discrimination was worse than when applied to patients without readmission (area under the RoC curve: <0.80 vs. >0.80) 12, 18 . The mortality of ICU readmission is known to be significantly higher than predicted according to our previous study and also other reports 1, 4, 10 . It is possible that some nosocomial complications leading to ICU readmission could be intrinsically associated with a higher attributable mortality and this excess attributable risk may not be related to the severity of their original illness (the first admission APACHE II predicted mortality) nor fully captured by the readmission APACHE II predicted mortality. This result and also the fact that the first admission APACHE II predicted mortality does not contribute further to the discrimination of readmission APACHE II predicted mortality suggests that diagnostic and physiology weightings of a prognostic model are far more important than events prior to ICU readmission when applied to patients readmitted to ICU during the same hospitalisation.
This study has limitations. First, this is a single centre study and our results may not be generalisable to other ICUs. Second, although we studied a reasonable number of ICU readmissions, the number of readmissions is insufficiently powered to allow subgroup analyses 25 . Furthermore, the nonsensical forms of the likelihood ratio such as the likelihood ratios going up and down sequentially are probably due to low precision of a small data set. Third, we used all available readmissions to assess the effect of combining the admission and readmission predicted mortality and could have resulted in an over-optimistic model. Finally, the APACHE II model does not adjust for the duration of hospitalisation prior to ICU admission. Although newer prognostic models such as the Simplified Acute Physiology Score III also did not include ICU readmissions in their original cohort 26 , some of these models do consider the length of hospital stay prior to the ICU admission. It is possible that these newer prognostic models may perform better than the APACHE II predicted mortality when applied to ICU readmissions during the same hospitalisation. The Australian and New Zealand Intensive Care Society adult patient database includes a large number of patients readmitted to the ICU during the same hospitalisation and will be very useful to develop and validate a new prognostic model for patients readmitted to the ICU during the same hospitalisation.
In summary, the readmission APACHE II predicted mortality only has a moderate ability to discriminate between survivors and non-survivors in patients readmitted to the ICU during the same hospitalisation. Incorporating the first ICU admission APACHE II predicted mortality to the readmission APACHE II predicted mortality, by either multilevel likelihood ratios or logistic regression, does not improve its discrimination significantly.
